In a 41-year-old man with primary hypogonadism, low SHBG, elevated FSH and LH, normal prolactin, low estradiol, and low testosterone despite daily testosterone gel (Androgel), what workup and treatment are recommended?

Primary Hypogonadism with Inadequate Response to Androgel: Workup and Treatment

This patient has primary (hypergonadotropic) hypogonadism with inadequate testosterone replacement despite daily Androgel, compounded by severely low SHBG that is masking the true severity of his free testosterone deficiency—you must measure free testosterone directly or calculate it, increase his testosterone dose to 7.5-10g daily per FDA dosing guidelines, and investigate the cause of his abnormally low SHBG. 1

Understanding the Clinical Picture

This 41-year-old has primary testicular failure confirmed by:

• Elevated FSH (20) and LH (15.10) indicating the pituitary is appropriately responding to low testosterone
• Total testosterone of only 80 ng/dL despite daily Androgel (severely hypogonadal)
• The elevated gonadotropins definitively establish this as primary, not secondary hypogonadism 2

Critical Issue: Severely Low SHBG

The SHBG of 8 nmol/L (decreased from 11) is pathologically low and creates a major diagnostic problem:

• Normal SHBG range is typically 10-57 nmol/L
• When SHBG is this low, total testosterone measurements are unreliable for assessing androgen status 2
• The Endocrine Society guideline explicitly states that free testosterone measurement is required in conditions with decreased SHBG, including obesity, diabetes, nephrotic syndrome, hypothyroidism, and glucocorticoid use 2
• Recent data confirms that in men with markedly elevated or decreased SHBG, free testosterone—not total testosterone—drives the hypothalamic-pituitary feedback loop 3

Immediate Workup Required

1. Measure Free Testosterone

• Calculate free testosterone using total testosterone and SHBG (equilibrium dialysis or calculated free T) 2
• This will reveal the true severity of his hypogonadism
• With SHBG this low, his bioavailable testosterone is likely even more deficient than the total testosterone suggests

2. Investigate the Low SHBG

The guideline lists specific conditions causing low SHBG that must be evaluated 2:

• Obesity: Check BMI and waist circumference
• Diabetes mellitus: HbA1c, fasting glucose
• Hypothyroidism: TSH, free T4
• Nephrotic syndrome: Urinalysis for proteinuria, serum albumin
• Glucocorticoid use: Medication history
• Acromegaly: If clinical features present (IGF-1)
• Hepatic dysfunction: Comprehensive metabolic panel, liver function tests

3. Determine Cause of Primary Hypogonadism

At age 41, primary hypogonadism requires investigation:

• Klinefelter syndrome (most common cause, affects 2 in 1000 men, often undiagnosed): Karyotype analysis 4
• Prior chemotherapy or radiation exposure
• Testicular trauma or torsion history
• Mumps orchitis
• Testicular examination for volume and consistency
• Scrotal ultrasound if structural abnormality suspected

4. Baseline Monitoring Labs Before Dose Escalation

Per FDA labeling, obtain 1:

• Hematocrit (testosterone increases erythropoiesis)
• PSA and digital rectal exam (age >40)
• Lipid panel
• Liver function tests

Treatment Strategy

Increase Androgel Dose Immediately

The FDA label provides clear dose escalation guidelines 1:

• Current dose: 5g daily (inadequate response with testosterone 80 ng/dL)
• Increase to 7.5g daily (6 pump actuations)
• If still inadequate after 2-4 weeks, escalate to 10g daily (8 pump actuations, maximum dose)
• The clinical trial data shows 87% of men achieved normal testosterone levels with appropriate titration 1

Critical application technique 1:

• Apply to shoulders, upper arms, and/or abdomen (NOT genitals)
• Allow to dry before dressing
• Wash hands after application
• Cover application sites with clothing to prevent transfer to partners (unprotected contact can transfer testosterone to female partners) 1

Alternative: Consider Switching Formulations

If maximum dose Androgel (10g) fails to achieve adequate levels:

• Testosterone injections (cypionate or enanthate) may be more reliable, especially with low SHBG
• Injections bypass skin absorption variability
• Typical dosing: 100-200mg intramuscularly every 1-2 weeks
• Consider this strongly given his current treatment failure

Address the Low SHBG

If obesity-related (most common cause) 4:

• Weight loss of ≥5% typically increases testosterone significantly
• Weight loss improves physical function, libido, and erectile function
• This is first-line management for obesity-induced hypogonadism, though this patient has primary hypogonadism requiring testosterone regardless

If other causes identified (hypothyroidism, diabetes, etc.):

• Treat the underlying condition
• This may improve SHBG and testosterone pharmacokinetics

Monitoring Plan

Recheck labs in 2-4 weeks after dose adjustment 1:

• Morning (7-10 AM) total testosterone
• Calculated free testosterone (essential with low SHBG)
• SHBG
• Hematocrit
• Target: Total testosterone 450-916 ng/dL, but free testosterone in normal range is the true goal 2, 3

Ongoing monitoring every 3-6 months:

• Testosterone levels (total and free)
• Hematocrit (watch for polycythemia)
• PSA (annually after age 40)
• Assess for BPH symptoms
• Lipids and liver function annually

Common Pitfalls to Avoid

1. Do not rely on total testosterone alone with SHBG <10 nmol/L—you will underestimate the severity of hypogonadism 2, 3

2. Do not accept treatment failure without dose escalation—the FDA label explicitly allows titration to 10g daily 1

3. Do not miss Klinefelter syndrome—it's common (2 in 1000 men) and frequently undiagnosed in adults 4

4. Do not ignore the low SHBG—it indicates an underlying metabolic or endocrine disorder requiring evaluation 2

5. Do not forget to counsel about transfer risk—skin-to-skin contact can transfer testosterone to partners; covering application sites with clothing prevents this completely 1

6. Do not continue inadequate gel therapy indefinitely—if 10g daily fails, switch to injections for more reliable delivery